一名接受抗表皮生长因子受体单克隆抗体西妥昔单抗治疗的头颈癌患者出现毛发异常生长。 - Suppr

Suppr

超能文献

Abnormal hair growth in a patient with head and neck cancer treated with the anti-epidermal growth factor receptor monoclonal antibody cetuximab.

作者信息

Montagut Clara, Grau Juan J, Grimalt Ramon, Codony Jordi, Ferrando Juan, Albanell Joan

出版信息

J Clin Oncol. 2005 Aug 1;23(22):5273-5. doi: 10.1200/JCO.2005.01.9570.

DOI:10.1200/JCO.2005.01.9570

PMID:16051981

Abstract

摘要

相似文献

Abnormal hair growth in a patient with head and neck cancer treated with the anti-epidermal growth factor receptor monoclonal antibody cetuximab.

J Clin Oncol. 2005 Aug 1;23(22):5273-5. doi: 10.1200/JCO.2005.01.9570.

Facial hypertrichosis induced by Cetuximab, an anti-EGFR monoclonal antibody.

Arch Dermatol. 2006 Dec;142(12):1656-7. doi: 10.1001/archderm.142.12.1656.

Cetuximab-induced hypertrichosis of the scalp and eyelashes.

J Am Acad Dermatol. 2010 Mar;62(3):531-3. doi: 10.1016/j.jaad.2009.02.023.

Trichomegaly and poliosis of the eyelashes during cetuximab treatment of metastatic colorectal cancer.

J Clin Oncol. 2011 Jun 20;29(18):e532-3. doi: 10.1200/JCO.2011.34.6858. Epub 2011 Apr 11.

Toxic epidermal necrolysis caused by cetuximab plus minocycline in head and neck cancer.

Am J Otolaryngol. 2010 Jul-Aug;31(4):288-90. doi: 10.1016/j.amjoto.2009.02.021. Epub 2009 Jun 3.

Trichomegaly of the eyelashes after colorectal cancer treatment with the epidermal growth factor receptor inhibitor cetuximab.

Clin Colorectal Cancer. 2009 Oct;8(4):235. doi: 10.3816/CCC.2009.n.040.

Targeting epidermal growth factor receptor in head and neck cancer: lessons learned from cetuximab.

Exp Biol Med (Maywood). 2010 Aug;235(8):907-20. doi: 10.1258/ebm.2009.009181. Epub 2010 Jun 18.

Cetuximab in the treatment of rheumatoid arthritis.

J Clin Rheumatol. 2010 Jan;16(1):32-3. doi: 10.1097/RHU.0b013e3181c8e176.

Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy.

J Clin Oncol. 2007 Jun 1;25(16):2171-7. doi: 10.1200/JCO.2006.06.7447.

The emerging role of cetuximab in head and neck cancer: a 2007 perspective.

Cancer Invest. 2008 Feb;26(1):96-103. doi: 10.1080/07357900701601002.

引用本文的文献

Hair disorders in patients with cancer.

J Am Acad Dermatol. 2019 May;80(5):1179-1196. doi: 10.1016/j.jaad.2018.03.055. Epub 2018 Apr 14.

Cetuximab: a review of its use in squamous cell carcinoma of the head and neck and metastatic colorectal cancer.

Drugs. 2007;67(17):2585-607. doi: 10.2165/00003495-200767170-00008.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Abnormal hair growth in a patient with head and neck cancer treated with the anti-epidermal growth factor receptor monoclonal antibody cetuximab.

作者信息

Montagut Clara, Grau Juan J, Grimalt Ramon, Codony Jordi, Ferrando Juan, Albanell Joan

出版信息

J Clin Oncol. 2005 Aug 1;23(22):5273-5. doi: 10.1200/JCO.2005.01.9570.

DOI:10.1200/JCO.2005.01.9570

PMID:16051981

Abstract

摘要

相似文献

Abnormal hair growth in a patient with head and neck cancer treated with the anti-epidermal growth factor receptor monoclonal antibody cetuximab.

J Clin Oncol. 2005 Aug 1;23(22):5273-5. doi: 10.1200/JCO.2005.01.9570.

Facial hypertrichosis induced by Cetuximab, an anti-EGFR monoclonal antibody.

Arch Dermatol. 2006 Dec;142(12):1656-7. doi: 10.1001/archderm.142.12.1656.

Cetuximab-induced hypertrichosis of the scalp and eyelashes.

J Am Acad Dermatol. 2010 Mar;62(3):531-3. doi: 10.1016/j.jaad.2009.02.023.

Trichomegaly and poliosis of the eyelashes during cetuximab treatment of metastatic colorectal cancer.

J Clin Oncol. 2011 Jun 20;29(18):e532-3. doi: 10.1200/JCO.2011.34.6858. Epub 2011 Apr 11.

Toxic epidermal necrolysis caused by cetuximab plus minocycline in head and neck cancer.

Am J Otolaryngol. 2010 Jul-Aug;31(4):288-90. doi: 10.1016/j.amjoto.2009.02.021. Epub 2009 Jun 3.

Trichomegaly of the eyelashes after colorectal cancer treatment with the epidermal growth factor receptor inhibitor cetuximab.

Clin Colorectal Cancer. 2009 Oct;8(4):235. doi: 10.3816/CCC.2009.n.040.

Targeting epidermal growth factor receptor in head and neck cancer: lessons learned from cetuximab.

Exp Biol Med (Maywood). 2010 Aug;235(8):907-20. doi: 10.1258/ebm.2009.009181. Epub 2010 Jun 18.

Cetuximab in the treatment of rheumatoid arthritis.

J Clin Rheumatol. 2010 Jan;16(1):32-3. doi: 10.1097/RHU.0b013e3181c8e176.

J Clin Oncol. 2007 Jun 1;25(16):2171-7. doi: 10.1200/JCO.2006.06.7447.

The emerging role of cetuximab in head and neck cancer: a 2007 perspective.

Cancer Invest. 2008 Feb;26(1):96-103. doi: 10.1080/07357900701601002.

引用本文的文献

Hair disorders in patients with cancer.

J Am Acad Dermatol. 2019 May;80(5):1179-1196. doi: 10.1016/j.jaad.2018.03.055. Epub 2018 Apr 14.

Cetuximab: a review of its use in squamous cell carcinoma of the head and neck and metastatic colorectal cancer.

Drugs. 2007;67(17):2585-607. doi: 10.2165/00003495-200767170-00008.